A drug that acts on a notoriously hard-to-target protein shows promise in a cat oral cancer clinical trial. It may someday help human patients, too. 



Summary

A new drug targeting a difficult-to-reach protein has shown promising results in a clinical trial for oral cancer in cats. This protein, often challenging for drug developers, plays a crucial role in cancer growth. The success observed in cats offers hope for potential future applications in human patients suffering from similar cancers. Further research and development are needed to translate these findings into effective treatments for both animal and human cancers.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer